New Research Highlights Cannabinoids and Fatty Liver Disease
Emerging cannabinoids fatty liver clinical relevance is gaining attention in recent studies. CBD and CBG show promise in improving fatty liver disease outcomes. Clinicians should monitor this evolving evidence carefully.
Judge Temporarily Blocks Texas Smokeable Hemp Ban
A temporary injunction texas hemp ban has been issued by a Texas judge, blocking the state's smokeable hemp ban. This ruling creates uncertainty for patient access to hemp products. Clinicians should monitor these regulatory changes closely.
Hemp Leaders Challenge Texas Intoxicating Smokables Ban
The texas intoxicating smokables ban has prompted hemp leaders to file a lawsuit challenging the new restrictions. This ban affects delta-8 THC products used by patients for symptom management. The legal challenge highlights ongoing regulatory…
Understanding the Effects of Cannabis Terpenes – CEAS Collective
Cannabis terpene research explores the effects of aromatic compounds found in cannabis. While clinical evidence is limited, understanding terpene profiles aids patient education. This research helps clinicians provide evidence-based guidance on terpene…
Two compounds found in cannabis plant reverse liver disease damage, study suggests
A recent study highlights cannabis compounds reverse liver disease damage in preclinical models. These findings suggest potential for new therapies targeting liver fibrosis. However, clinical trials are needed to confirm safety and efficacy.
Deeper Sleep, Not Just More Sleep | Flourish + Live Well
Sleep architecture cannabinoids influence sleep quality by enhancing deep sleep phases rather than just increasing total sleep time. This distinction is crucial for cognitive function and immune response. Understanding these effects helps clinicians…
Dietary Bioactives in Alzheimer’s Disease: A Critical Appraisal of Clinical Trials and Future Directions
This review critically examines dietary bioactives alzheimer s disease clinical trials, focusing on cannabinoids and other compounds. It provides clinicians with an evidence-based assessment to distinguish promising treatments from marketing claims.…
Cannabis-based interventions might help a little with neuropathic pain – Study Summary
Cannabis neuropathic pain relief shows modest improvements in patients with challenging neuropathic pain. Studies reveal small to moderate benefits from cannabis-based interventions. This evidence supports cautious use as adjunct therapy for neuropathic…
Cannabinoids in Children: Clinical Evidence Review
The cannabinoids pediatric safety evidence review covers clinical research spanning 276 studies on cannabinoid use in children. This evolving evidence base reflects growing interest and cautious interpretation due to limited long-term safety data.…
CBN Launches Supervisory Pilot to Tackle Virtual Asset Risks
The CBN virtual asset supervisory pilot addresses emerging risks in Nigeria's cryptocurrency market. This initiative represents a significant step in financial supervision. Understanding the CBN virtual asset supervisory pilot is essential for…